Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer
Clinical trial NCT04829890 · COMPLETED
Trial details
- NCT number
- NCT04829890
- Sponsor
- Hellenic Cooperative Oncology Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2004-02-01
- Primary completion
- 2006-04-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.